Connect with us

Hi, what are you looking for?

Sports

Cavs forward suspended 25 games for violating NBA Anti-Drug Program

The Cleveland Cavaliers will be without Tristan Thompson for roughly the next two months.

Thompson has been suspended 25 games by the NBA for violating the league’s NBA/NBPA Anti-Drug Program. He tested positive for ibutamoren and SARM LGD-4033, both of which are considered performance enhancers, according to a league statement.

Thompson’s suspension will begin with Wednesday’s game against the Milwaukee Bucks. He’ll be eligible to return from the suspension for the Cavs’ March 16 game against the Houston Rockets.

This past offseason, Thompson signed a one-year deal with the Cavs worth just north of $3.1 million. Off the bench, he’s averaged 3.8 points and 3.9 rebounds in 12.4 minutes per game.

What is ibutamoren? Tristan Thompson suspended for violation

Ibutamoren is a potent, orally-active drug that helps to increase growth hormone production. It’s often used as a regenerative medicine for adults struggling with age-related medical conditions. It’s noted by the World Anti-Doping Agency as a dangerous chemical substance.

What is SARM LGD-4033?

Ryan Lewis can be reached at rlewis@thebeaconjournal.com. Follow him on X at @ByRyanLewis.

This post appeared first on USA TODAY

    You May Also Like

    Politics

    When George Santos mentioned his family during his congressional campaign, the New York Republican often reflected on the work ethic and strength of his...

    Business

    Two of Sam Bankman-Fried’s top business partners — a co-founder of the cryptocurrency exchange FTX and the former CEO of the hedge fund Alameda...

    Sports

    Kicker Alejandro Mata is following former Tigers coach Deion Sanders to Colorado. ‘Thankful to be committed and signed to the University of Colorado,’ Marta wrote on...

    Stocks

    SPX Monitoring Purposes: Sold long SPX 1/27/23 at 4070.56 = Gain 6.51%; Long on 12/20/22 at 3821.62. The top window is the cumulative GDX...

    Disclaimer: SecretCharts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 SecretCharts.com | All Rights Reserved